Interferon beta remains a cornerstone disease-modifying therapy in relapsing forms of multiple sclerosis. However, its utility is compromised by immunogenicity, whereby patients develop anti-drug ...
Elevated interferon alfa levels mark a subgroup of Sjögren disease, revealing immune changes years before diagnosis, and mice studies mirror these findings.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results